Episode
Beyond Stage IV: Rethinking Oligometastatic Lung Cancer
- Podcast
- Lung Cancer Considered
- Published
- Sep 1, 2026
- Duration seconds
- 2850
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/beyond-stage-iv-rethinking-oligometastatic-lung-cancer/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/lung-cancer-considered-246259/beyond-stage-iv-rethinking-oligometastatic-lung-cancer.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, Dr. Narjust Florez is joined by Dr. Yasir Elamin and Dr. Liliana Faroni to explore the evolving management of oligometastatic lung cancer. They break down key definitions, discuss when and how to use consolidative therapies like radiation and surgery, and examine patient selection, limitations, and emerging tools such as ctDNA that are shaping a more precise approach to care. Guests: Yasir Elamin, MD Associate Professor of Thoracic Medical University of Texas MD Anderson Cancer Center Liliana Faroni, MD, PhD Radiation Oncologist, Oncologia D’Or Rio de Janeiro